Skip to main content
GutCited

Bifidobacterium lactis لـ Chronic Constipation

B

Dose-dependently reduces whole gut transit time (WGTT). Higher dose (17.2 billion CFU) showed 31% reduction in WGTT. Also reduces functional GI symptoms.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbifidobacterium\u002Dlactis\u0026condition\u003Dconstipation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

الخلاصة

Dose-dependently reduces whole gut transit time (WGTT). Higher dose (17.2 billion CFU) showed 31% reduction in WGTT. Also reduces functional GI symptoms.

Key Study Findings

Randomized Controlled Trial 8 weeks Double-blind
Effect of an 8-Week Bifidobacterium lactis HN019 Supplementation on Functional Constipation: A Multi-Center, Triple-Blind, Randomized, …
Dose: None مقابل: Placebo Outcome: Complete spontaneous bowel movements (CSBMs) التأثير: None None

المجتمع المدروس: Adults with functional constipation (Rome III)

Randomized Controlled Trial n=67 4 weeks Double-blind
Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with …
Dose: None مقابل: Placebo Outcome: Weekly spontaneous bowel movements التأثير: 4.94 vs 3.00 (P<0.001) P<0.001

المجتمع المدروس: Older adults >=60 with functional constipation (Rome IV)

Randomized Controlled Trial n=35 12 weeks Double-blind
Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable …
Dose: None مقابل: Placebo Outcome: Gut barrier function (zonulin levels) التأثير: Zonulin -19.5 ng/mL at week 16 p=0.0002 wk16; p=0.0053 grp

المجتمع المدروس: IBS without constipation patients

Review
An update on probiotics in paediatrics.
Dose: None مقابل: None Outcome: GI disorder outcomes in paediatrics التأثير: None None

المجتمع المدروس: Paediatric patients with GI disorders

In Vitro n=35
A Probiotic Mixture of Lactobacillus rhamnosus LR 32, Bifidobacterium lactis BL 04, and Bifidobacterium longum …
Dose: 1e6 CFU/mL مقابل: IBS supernatants without probiotic Outcome: Caco-2 paracellular permeability التأثير: None <0.001

المجتمع المدروس: IBS patients (28) and asymptomatic controls (7)

Randomized Controlled Trial n=128 2 weeks Double-blind
Probiotics and Fever Duration in Children With Upper Respiratory Tract Infections: A Randomized Clinical Trial.
Dose: 0.5 mL daily for 14 days مقابل: Placebo Outcome: Fever duration (days) التأثير: RR 0.64 (95% CI 0.51-0.80) None

المجتمع المدروس: Children 28 days-4 years with fever and URTI

Key Statistics

4

الدراسات

600

المشاركون

Positive

B

التقييم

Referenced Papers

Current opinion in … 2025
Pediatric gastroenterology, hepatology … 2017 27 اقتباسات
World journal of … 2010 276 اقتباسات

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

الجرعات الشائعة

general:
1-10 billion CFU/day
immunesupport:
5-10 billion CFU/day
constipationsupport:
17.2 billion CFU/day (HN019 strain, optimal dose)

الحد الأعلى: Well-tolerated up to 17.2 billion CFU/day in clinical trials

الجرعات المدروسة في الأبحاث

الجرعة المدة التأثير ن
None 8 weeks Neutral --
None 4 weeks Positive 67
None 12 weeks Positive 35
None -- Positive --
1e6 CFU/mL -- Positive 35
0.5 mL daily for 14 days 2 weeks Positive 128
None 2 weeks Negative 117
10 g 4 weeks Positive --

أفضل وقت للتناول: With or without food; morning dosing may be optimal for transit effects

Safety & Side Effects

الآثار الجانبية المُبلّغ عنها

  • Mild gas and bloating during initial use
  • Occasional abdominal discomfort
  • Rare loose stools
  • Very rare: bacteremia in immunocompromised individuals

التفاعلات المعروفة

  • Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
  • Immunosuppressants (use with caution in immunocompromised patients)

الحد الأقصى المسموح به: Well-tolerated up to 17.2 billion CFU/day in clinical trials

استشر مقدم الرعاية الصحية دائماً قبل البدء بأي مكمل غذائي.

Frequently Asked Questions

Does Bifidobacterium lactis help with Chronic Constipation?
Based on 4 studies with 600 participants, there is moderate evidence from clinical studies that Bifidobacterium lactis may support Chronic Constipation management. Our evidence grade is B (Good Evidence).
How much Bifidobacterium lactis should I take for Chronic Constipation?
Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Bifidobacterium lactis?
Reported side effects may include Mild gas and bloating during initial use, Occasional abdominal discomfort, Rare loose stools, Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Bifidobacterium lactis and Chronic Constipation?
We rate the evidence as Grade B (Good Evidence). This rating is based on 4 peer-reviewed studies with 600 total participants. The overall direction of effect is positive.

Related Evidence

مكونات أخرى لـ Chronic Constipation

إخلاء مسؤولية FDA: لم تُقيَّم هذه البيانات من قبل إدارة الغذاء والدواء (FDA). لا تهدف المنتجات والمعلومات الواردة في هذا الموقع إلى تشخيص أو علاج أو شفاء أو الوقاية من أي مرض. تستند تقييمات الأدلة المعروضة إلى تحليلنا للأبحاث المحكّمة المنشورة ولا تُشكّل نصيحة طبية. استشر مقدم الرعاية الصحية دائماً قبل البدء بأي نظام مكملات.